BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19720480)

  • 1. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
    Øren A
    Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
    Bakken K; Eggen AE; Lund E
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
    J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
    Thunell L; Stadberg E; Milsom I; Mattsson LA
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):395-401. PubMed ID: 15762973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone replacement therapy--women's expectations and fears].
    Schultz-Zehden B
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):180-8. PubMed ID: 10802891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study.
    Kuo DJ; Lee YC; Huang WF
    Maturitas; 2007 Nov; 58(3):259-68. PubMed ID: 17920215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
    Trinh XB; Peeters F; Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance considerations with hormone replacement therapy.
    Karakoç B; Erenus M
    Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuation of hormone replacement therapy after hysterectomy.
    Domoney C; Studd JW; Mocroft A
    Climacteric; 2003 Mar; 6(1):58-66. PubMed ID: 12725666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy: attitude and acceptance of Bangkokian women.
    Taechakraichana N; Wilawan K; Wipatavit V; Maitrisathit S; Thamanavat N; Jaisamrarn U; Panyakhamlerd K; Havanond P; Limpaphayom KK
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S385-98. PubMed ID: 12930015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms.
    Lindh-Astrand L; Bixo M; Hirschberg AL; Sundström-Poromaa I; Hammar M
    Menopause; 2010; 17(1):72-9. PubMed ID: 19675505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the use of Hormone Replacement Therapy in New Zealand following the publication of the Women's Health Initiative trial.
    Bilgrami I; Blower K; Feng J; Stefanko G; Tan E
    N Z Med J; 2004 Nov; 117(1206):U1175. PubMed ID: 15570344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
    Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.